Hunter Toyoda

Hunter Toyoda

Auto-generated profile, based on publicly available information

Hunter Toyoda

Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2012 in Annals of Applied Biology
Verified
Journal Article
Closed access
PDF file
KKK. Kakutani
K. Kakutani
Yoshinori MatsudaYoshinori Matsuda
Yoshinori Matsuda
KHK. Haneda
K. Haneda
TNTeruo Nonomura
Teruo Nonomura
JKJ. Kimbara
J. Kimbara
HTH. Toyoda
H. Toyoda

1 July 2006 in Plant Disease
Verified
Journal Article
Open access
WOW. Oichi
W. Oichi
Yoshinori MatsudaYoshinori Matsuda
Yoshinori Matsuda
TNTeruo Nonomura
Teruo Nonomura
HTH. Toyoda
H. Toyoda
LXLing Xu
Ling Xu
SKS. Kusakari
S. Kusakari
The formation of conidial pseudochains by the tomato powdery mildew Oidium neolycopersici on tomato leaves was monitored using a high-fidelity digital microscope. Individual living conidiophores that formed mature conidial cells at their apex were selected for observation. The conidial cells were produced during repeated division and elongation by the generative cells of the conidiophores. Under weak wind conditions (0.1 m/s), these conidial cells did not separate from each other to produce a chain of conidial cells (pseudochain). The pseudochains dropped from the conidiophores once four conidial cells were connected. The conidiophores resumed conidium production, followed by another cycle of pseudochain formation. The formation of pseudochains by tomato powdery mildew was not influenced by the ambient relative humidity. On the other hand, the conidial cells produced were easily wind dispersed without forming pseudochains when conidiophores were exposed to stronger winds (1.0 m/s). The present study successfully demonstrated that the pathogen required wind to disperse progeny conidia from the conidiophores and produced conidial pseudochains when the wind was below a critical level, independent of high relative humidity as reported previously.

31 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRenee B. Chang
Renee B. Chang
HTHunter C. Toyoda
Hunter C. Toyoda
SHSamuel J. Hobbs
Samuel J. Hobbs
DRDesmond Richmond-Buccola
Desmond Richmond-Buccola
TWTanita Wein
Tanita Wein
PKPhilip J. Kranzusch
Philip J. Kranzusch
Summary: Cyclic oligonucleotide-based antiviral signaling systems (CBASS) are bacterial anti-phage defense operons that use nucleotide signals to control immune activation. Here we biochemically screen 57 diverse E. coli and Bacillus phages for the ability to disrupt CBASS immunity and discover anti-CBASS 4 (Acb4) from the Bacillus phage SPO1 as the founding member of a large family of >1,300 immune evasion proteins. A 2.1 Å crystal structure of Acb4 in complex with 3′3′-cGAMP reveals a tetrameric assembly that functions as a sponge to sequester CBASS signals and inhibit immune activation. We demonstrate Acb4 alone is sufficient to disrupt CBASS activation in vitro and enable immune evasion in vivo . Analyzing phages that infect diverse bacteria, we explain how Acb4 selectively targets nucleotide signals in host defense and avoids disruption of cellular homeostasis. Together, our results reveal principles of immune evasion protein evolution and explain a major mechanism phages use to inhibit host immunity.

21 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DRDesmond Richmond-Buccola
Desmond Richmond-Buccola
SHSamuel J. Hobbs
Samuel J. Hobbs
JGJasmine M. Garcia
Jasmine M. Garcia
HTHunter Toyoda
Hunter Toyoda
JGJingjing Gao
Jingjing Gao
PKPhilip J. Kranzusch
Philip J. Kranzusch
SUMMARY: CBASS is an anti-phage defense system that protects bacteria from phage infection and is evolutionarily related to human cGAS-STING immunity. cGAS-STING signaling is initiated by viral DNA but the stage of phage replication which activates bacterial CBASS remains unclear. Here we define the specificity of Type I CBASS immunity using a comprehensive analysis of 975 operon-phage pairings and show that Type I CBASS operons composed of distinct CD-NTases, and Cap effectors exhibit striking patterns of defense against dsDNA phages across five diverse viral families. We demonstrate that escaper phages evade CBASS immunity by acquiring mutations in structural genes encoding the prohead protease, capsid, and tail fiber proteins. Acquired CBASS resistance is highly operon-specific and typically does not affect overall fitness. However, we observe that some resistance mutations drastically alter phage infection kinetics. Our results define late-stage virus assembly as a critical determinant of CBASS immune activation and evasion by phages.